Operating Lease, Liability of Monopar Therapeutics from 31 Mar 2021 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Monopar Therapeutics quarterly Operating Lease, Liability in USD history and change rate from 31 Mar 2021 to 30 Sep 2025.
Monopar Therapeutics Operating Lease, Liability for the quarter ending 30 Sep 2025 was $102,236.
Source SEC data: View on sec.gov

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Monopar Therapeutics Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$102,236	+$102,236		30 Sep 2025	10-Q	13 Nov 2025	2025	Q3
Q2 2025	$113,740	+$113,740		30 Jun 2025	10-Q	12 Aug 2025	2025	Q2
Q3 2024	$0			30 Sep 2024	10-Q	13 Nov 2025	2025	Q3
Q2 2024	$0			30 Jun 2024	10-Q	12 Aug 2025	2025	Q2
Q4 2023	$8,408	-$48,582	-85%	31 Dec 2023	10-K	28 Mar 2024	2023	FY
Q4 2022	$56,990	+$56,990		31 Dec 2022	10-K	28 Mar 2024	2023	FY
Q3 2022	$68,651	+$68,651		30 Sep 2022	10-Q	10 Nov 2022	2022	Q3
Q2 2022	$80,125	+$80,125		30 Jun 2022	10-Q	11 Aug 2022	2022	Q2
Q1 2022	$51,315	+$51,315		31 Mar 2022	10-Q	12 May 2022	2022	Q1
Q4 2021	$0			31 Dec 2021	10-K	23 Mar 2023	2022	FY
Q3 2021	$0			30 Sep 2021	10-Q	10 Nov 2022	2022	Q3
Q2 2021	$0			30 Jun 2021	10-Q	11 Aug 2022	2022	Q2
Q1 2021	$0			31 Mar 2021	10-Q	12 May 2022	2022	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.